Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg, Heidelberg, Germany.
Gastroenterology. 2018 Jun;154(8):2237-2251.e16. doi: 10.1053/j.gastro.2018.03.020. Epub 2018 Mar 11.
BACKGROUND & AIMS: Hepatitis C virus (HCV) infections most often result in chronic outcomes, although the virus constantly produces replication intermediates, in particular double-stranded RNA (dsRNA), representing potent inducers of innate immunity. We aimed to characterize the fate of HCV dsRNA in hepatocyte cultures to identify mechanisms contributing to viral persistence in presence of an active innate immune response.
We analyzed hepatocyte-based culture models for HCV for induction of innate immunity, secretion of virus positive- or negative-strand RNA, and viral replication using different quantification methods and microscopy techniques. Expression of pattern recognition receptors was reconstituted in hepatoma cells by lentiviral transduction.
HCV-infected cells secrete substantial amounts of virus positive- and negative-strand RNAs in extracellular vesicles (EVs), toward the apical and basolateral domain of hepatocytes. Secretion of negative-strand RNA was independent from virus production, and viral RNA secreted in EVs contained higher relative amounts of negative-strands, indicating that mostly virus dsRNA is released. A substantial part of viral replication complexes and dsRNA was found in the endosomal compartment and multivesicular bodies, indicating that secretion of HCV replication intermediates is mediated by the exosomal pathway. Block of vesicle release in HCV-positive cells increased intracellular dsRNA levels and increased activation of toll-like receptor 3, inhibiting HCV replication.
Using hepatocyte-based culture models for HCV, we found a portion of HCV dsRNA intermediates to be released from infected cells in EVs, which reduces activation of toll-like receptor 3. This represents a novel mechanism how HCV evades host immune responses, potentially contributing to viral persistence.
丙型肝炎病毒(HCV)感染通常导致慢性结局,尽管该病毒不断产生复制中间体,尤其是双链 RNA(dsRNA),代表先天免疫的有效诱导物。我们旨在研究 HCV dsRNA 在肝细胞培养物中的命运,以确定在存在活跃的先天免疫反应的情况下导致病毒持续存在的机制。
我们使用不同的定量方法和显微镜技术,分析基于肝细胞的 HCV 培养模型以诱导先天免疫、病毒正链或负链 RNA 的分泌以及病毒复制。通过慢病毒转导在肝癌细胞中重建模式识别受体的表达。
HCV 感染的细胞以细胞外囊泡(EVs)的形式向肝细胞的顶侧和基底外侧区域分泌大量的病毒正链和负链 RNA。负链 RNA 的分泌不依赖于病毒产生,并且在 EVs 中分泌的病毒 RNA 含有更高比例的负链,表明主要释放的是病毒 dsRNA。大量的病毒复制复合物和 dsRNA 位于内体区室和多泡体中,表明 HCV 复制中间体的分泌是通过细胞外体途径介导的。在 HCV 阳性细胞中阻断囊泡释放会增加细胞内 dsRNA 水平并增加 Toll 样受体 3 的激活,从而抑制 HCV 复制。
使用基于肝细胞的 HCV 培养模型,我们发现一部分 HCV dsRNA 中间体以 EVs 的形式从感染细胞中释放出来,从而降低了 Toll 样受体 3 的激活。这代表了 HCV 逃避宿主免疫反应的一种新机制,可能有助于病毒持续存在。